- Home
- Publications
- Publication Search
- Publication Details
Title
Perspectives in allergen immunotherapy: 2019 and beyond
Authors
Keywords
-
Journal
ALLERGY
Volume 74, Issue S108, Pages 3-25
Publisher
Wiley
Online
2019-12-24
DOI
10.1111/all.14077
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and reproducibility of nasal allergen challenge
- (2019) Ibon Eguiluz-Gracia et al. ALLERGY
- Towards clinically applicable biomarkers for asthma – An EAACI position paper
- (2019) Zuzana Diamant et al. ALLERGY
- EAACI Guidelines on Allergen Immunotherapy: House dust mite‐driven allergic asthma
- (2019) Ioana Agache et al. ALLERGY
- Randomized immunotherapy trial in dual‐allergic patients using “active allergen placebo” as control
- (2019) Martin Wagenmann et al. ALLERGY
- Clinical trials in allergen immunotherapy: current concepts and future needs
- (2018) O. Pfaar et al. ALLERGY
- Perspectives in allergen immunotherapy: 2017 and beyond
- (2018) O. Pfaar et al. ALLERGY
- Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients
- (2018) R. Mösges et al. ALLERGY
- EAACI Position paper on the standardization of nasal allergen challenges
- (2018) J. Augé et al. ALLERGY
- Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project
- (2018) A. Bonertz et al. ALLERGY
- Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trial
- (2018) R. Mösges et al. ALLERGY
- Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32
- (2018) Verena Niederberger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Activated PI3 Kinase Delta Syndrome: From Genetics to Therapy
- (2018) David Michalovich et al. Frontiers in Immunology
- Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma
- (2018) Ulrich Wahn et al. ALLERGY
- Recent Developments and Highlights in rhinitis and allergen immunotherapy
- (2018) S. Reitsma et al. ALLERGY
- Recent developments and highlights in allergen immunotherapy
- (2018) Oliver Pfaar et al. ALLERGY
- Sublingual allergen immunotherapy with a liquid birch pollen product in seasonal allergic rhinoconjunctivitis with/without asthma*
- (2018) Oliver Pfaar et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Early IL-10 producing B-cells and coinciding Th/Tr17 shifts during three year grass-pollen AIT
- (2018) Ulrich M. Zissler et al. EBioMedicine
- Placeboeffekt in Studien zur allergenspezifischen Immuntherapie mit Inhalationsallergenen
- (2017) B. Wedi et al. HAUTARZT
- Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis
- (2017) Guy W. Scadding et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Validation of the Global Allergy and Asthma European Network (GA 2 LEN) chamber for trials in allergy: Innovation of a mobile allergen exposure chamber
- (2017) Torsten Zuberbier et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers
- (2017) Mohamed H. Shamji et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Antiapoptotic serine protease inhibitors contribute to survival of allergenic T H 2 cells
- (2017) Mohamed H. Shamji et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma
- (2016) J. Christian Virchow et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Field Scores of Allergic Individuals Correlate Positively with Self-Reported Outdoor Exposure Collected Using an Electronic Patient Data Acquisition Tablet (ePDAT™)
- (2016) Tara Sadoway et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis—PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology
- (2016) Antonella Muraro et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Changes in markers associated with dendritic cells driving the differentiation of either TH2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapy
- (2016) Claire Gueguen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Histamine-secreting microbes are increased in the gut of adult asthma patients
- (2016) Weronika Barcik et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry
- (2016) Joan Sweeney et al. THORAX
- Endotypes of allergic diseases and asthma: An important step in building blocks for the future of precision medicine
- (2016) Ioana Agache et al. ALLERGOLOGY INTERNATIONAL
- Environmental exposure chambers in allergen immunotherapy trials: Current status and clinical validation needs
- (2015) Karen Rösner-Friese et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Asthma
- (2015) Stephen T. Holgate et al. Nature Reviews Disease Primers
- Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial
- (2015) Ludger Klimek et al. Clinical and Translational Allergy
- Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper
- (2014) O. Pfaar et al. ALLERGY
- Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: A randomized, double-blind, placebo-controlled trial
- (2014) Holger Mosbech et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Preventive sublingual immunotherapy in preschool children: First evidence for safety and pro-tolerogenic effects
- (2014) Zsolt Szépfalusi et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- External validation of blood eosinophils, FENOand serum periostin as surrogates for sputum eosinophils in asthma
- (2014) A H Wagener et al. THORAX
- Double-blind, placebo-controlled, dose-ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber
- (2013) W. Meyer et al. ALLERGY
- Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial
- (2013) Jennifer Maloney et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis
- (2013) A. Didier et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Efficacy of sublingual immunotherapy for allergic asthma: retrospective meta-analysis of randomized, double-blind and placebo-controlled trials
- (2013) Lianqin Tao et al. Clinical Respiratory Journal
- Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults
- (2013) Peter S. Creticos et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Prophylactic use of sublingual allergen immunotherapy in high-risk children: A pilot study
- (2013) Patrick G. Holt et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Placebo analgesia: Psychological and neurobiological mechanisms
- (2013) Luana Colloca et al. PAIN
- The placebo effect in allergen-specific immunotherapy trials
- (2013) Annemie Narkus et al. Clinical and Translational Allergy
- Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study
- (2012) L. Klimek et al. CLINICAL AND EXPERIMENTAL ALLERGY
- SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial
- (2012) Stephen R. Durham et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Prospective validation of the "rhino conjunctivitis allergy-control-SCORE(C)" (RC-ACS(C))
- (2012) Dietrich Häfner et al. Clinical and Translational Allergy
- Prospective validation of ‘Allergy-Control-SCORETM’: a novel symptom-medication score for clinical trials
- (2011) D. Häfner et al. ALLERGY
- Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen
- (2011) Lawrence M. DuBuske et al. ALLERGY AND ASTHMA PROCEEDINGS
- Anti-allergic drug testing in an environmental challenge chamber is suitable both in and out of the relevant pollen season
- (2011) Philipp Badorrek et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Allergen-Specific Immunotherapy: Which Outcome Measures are Useful in Monitoring Clinical Trials?
- (2011) O. Pfaar et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Lebrikizumab Treatment in Adults with Asthma
- (2011) Jonathan Corren et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now